(Q44332403)

2 December 2017

title

Micro opioid receptor A118G polymorphism and post-operative pain: opioids' effects on heterozygous patients (English)

1 reference

2 December 2017

0 references

1 reference

1 reference

A De Capraris

1

1 reference

2 December 2017

G Cinnella

2

1 reference

2 December 2017

A Marolla

3

1 reference

2 December 2017

P Salatto

4

1 reference

2 December 2017

S Da Lima

5

1 reference

2 December 2017

P Vetuschi

6

1 reference

2 December 2017

L Consoletti

7

1 reference

2 December 2017

L Gesualdo

8

1 reference

2 December 2017

M Dambrosio

9

1 reference

2 December 2017

publication date

1 October 2011

1 reference

International Journal of Immunopathology and Pharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

24

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

993-1004

1 reference

The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Are mu-opioid receptor polymorphisms important for clinical opioid therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Genetic factors in pain and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Modulation of Ca2+ channels by heterologously expressed wild-type and mutant human micro-opioid receptors (hMORs) containing the A118G single-nucleotide polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

How individual sensitivity to opiates can be predicted by gene analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Population-specific effects of the Asn40Asp polymorphism at the mu-opioid receptor gene (OPRM1) on HPA-axis activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Genetic modulation of the pharmacological treatment of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400417

10.1177/039463201102400417

21 January 2018

Identifiers

DOI

0 references

1 reference